↓ Skip to main content

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Overview of attention for article published in BMC Cancer, November 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
63 Mendeley